Ownership history in XPONANCE LLC · 3 quarters on record
This page tracks every 13F SEC filing in which XPONANCE LLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 5,488 | +24 | +0.4% | 0.00% | $261K | — |
| 2025 Q2 | REDUCED | 5,464 | -101 | -1.8% | 0.00% | $292K | — |
| 2025 Q1 | INITIATED | 5,565 | — | — | 0.00% | $225K | — |